Lumos Pharma, Inc.

Ownership Transactions Reported by 13 Insiders

Location
4200 Marathon Blvd., Suite 200, Austin, TX

There are no Buy or Sell transactions made by insiders since 11/30/2024

Lumos Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David B. Karpf Chief Medical Officer $26.6K Feb 1, 2023
Lota S. Zoth Director $0 Dec 12, 2024
Bradley J. Powers General Counsel $0 Dec 12, 2024
Chad Allen Johnson Director $0 Dec 12, 2024
Kevin M. Lalande Director $0 Dec 12, 2024
Joseph S. McCracken Director $0 Dec 12, 2024
Thomas A. Raffin Director $0 Dec 12, 2024
Aaron Schuchart Chief Business Officer $0 Dec 12, 2024
Lori D. Lawley Chief Financial Officer $0 Dec 12, 2024
An van Es-Johansson Director $0 Dec 12, 2024
Richard Hawkins Chief Executive Officer, Director $0 Dec 12, 2024
Pisit Duke Pitukcheewanont Chief Medical Officer $0 Dec 12, 2024
John C. McKew Chief Scientific Officer $0 Dec 12, 2024

Recent Insider Transactions by Companies or Individuals for Lumos Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.